what is more effective for weight loss semaglutide or tirzepatide caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide The Weight Loss Program: Semaglutide

Never recap a needle

BPC-157 promotes angiogenesis, which raises questions about use in individuals with active cancers where blood vessel growth could support tumor progression

Contraindications: Do not exceed the recommended dose

Patients should be ready to adjust their lifestyle if recommended

There is still so much we dont know about the human body

Patient Considerations Review the following questions with your healthcare provider to decide if Mounjaro is right for you: Do you have other medical conditions, including problems with your pancreas or kidneys, or severe stomach problems, such as delayed stomach emptying or trouble digesting food